Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
US5552422A · kind A · utility
217Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 1995 |
| Grant date | Sep 3, 1996 |
| Priority date | — |
| Expiry date | Jan 11, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.